Tech Company Financing Transactions
Kerna Laboratories Funding Round
Kerna Laboratories, based in San Francisco, received investment capital from Gradient Ventures, Humba Ventures and private investors.
Transaction Overview
Company Name
Announced On
1/13/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Seed
Investors
private investors (Jacob Kimmel)
private investors (Patrick Hsu)
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1025 Minna St
San Francisco, CA 94103
USA
San Francisco, CA 94103
USA
Phone
Undisclosed
Website
Email Address
Overview
We are revolutionizing genetic medicine; We are paving the way for a new generation of therapies by leveraging AI and high-throughput biology to decode RNA biology. Kerna Labs is unlocking the full potential of mRNA as the universal toolkit for genetic medicine. We leverage advanced computational techniques and high-throughput biology to fundamentally change the way we do drug discovery and development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Julia Peng
Chief Technical Officer
Amit Deshwar
Co-Founder
Melissa Moore
Browse more venture capital transactions:
Prev: 1/13/2025: Normunity venture capital transaction
Next: 1/13/2025: Tune Therapeutics venture capital transaction
Share this article
News on VC Transactions
We do our best to record every notable VC transaction. All VC database entries reported here come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs